tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

INMB Stock Latest News

Raymond James Predicts Up to ~930% Rally for These 2 ‘Strong Buy’ Stocks
Stock Analysis & IdeasRaymond James Predicts Up to ~930% Rally for These 2 ‘Strong Buy’ Stocks
7d ago
BDTX
INMB
INmune Bio treatment of epidermolysis bullosa receives FDA orphan designation
PremiumThe Fly
INmune Bio treatment of epidermolysis bullosa receives FDA orphan designation
12d ago
INMB
Inmune Bio Announces Stock Options and Leadership Changes
PremiumCompany Announcements
Inmune Bio Announces Stock Options and Leadership Changes
1M ago
8K
INMB
INmune Bio, OmniScience announce partnership to accelerate Alzheimer’s trial
PremiumThe Fly
INmune Bio, OmniScience announce partnership to accelerate Alzheimer’s trial
2M ago
INMB
INmune Bio, OmniScience partner to accelerate trial with Vivo
PremiumThe Fly
INmune Bio, OmniScience partner to accelerate trial with Vivo
2M ago
INMB
INmune Bio announces enrollment of 208 patients in Phase 2 trial of early AD
PremiumThe FlyINmune Bio announces enrollment of 208 patients in Phase 2 trial of early AD
2M ago
INMB
Inmune Bio Emerges as Biotech Innovator in 2023
Premium
Company Announcements
Inmune Bio Emerges as Biotech Innovator in 2023
2M ago
8K
INMB
INmune Bio holds an investor and analyst webinar
Premium
The Fly
INmune Bio holds an investor and analyst webinar
2M ago
INMB
Inmune Bio Reports Increased Losses Amid Financing Efforts
PremiumCompany Announcements
Inmune Bio Reports Increased Losses Amid Financing Efforts
3M ago
INMB
Inmune Bio (INMB) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Inmune Bio (INMB) Q3 Earnings Cheat Sheet
3M ago
INMB
INmune Bio to host webinar on cognitive testing using EMACC, CDR-SB
PremiumThe Fly
INmune Bio to host webinar on cognitive testing using EMACC, CDR-SB
3M ago
INMB
INmune Bio announces publication of XPro1595 data in Cell Reports
PremiumThe Fly
INmune Bio announces publication of XPro1595 data in Cell Reports
3M ago
INMB
INmune Bio initiated with a Buy at Alliance Global Partners
PremiumThe FlyINmune Bio initiated with a Buy at Alliance Global Partners
3M ago
INMB
INmune Bio completes enrollment for Phase 2 trial in Early AD
Premium
The Fly
INmune Bio completes enrollment for Phase 2 trial in Early AD
4M ago
INMB
INmune Bio initiated with an Outperform at Raymond James
Premium
The Fly
INmune Bio initiated with an Outperform at Raymond James
4M ago
INMB
INmune Bio initiated with an Outperform at Raymond James
PremiumThe Fly
INmune Bio initiated with an Outperform at Raymond James
4M ago
INMB
INmune announces initial results from Phase I/II trial of INKmune with mCRPC
PremiumThe Fly
INmune announces initial results from Phase I/II trial of INKmune with mCRPC
4M ago
INMB
INmune Bio announces results of additional interim analysis of Phase 2 trial
PremiumThe Fly
INmune Bio announces results of additional interim analysis of Phase 2 trial
4M ago
INMB
INmune Bio initiated with an Outperform at Scotiabank on Alzheimer’s potential
PremiumThe Fly
INmune Bio initiated with an Outperform at Scotiabank on Alzheimer’s potential
5M ago
INMB
Scotiabank starts INmune with Outperform on Alzheimer’s potential
PremiumThe FlyScotiabank starts INmune with Outperform on Alzheimer’s potential
5M ago
INMB
INmune Bio initiated with an Outperform at Scotiabank
Premium
The Fly
INmune Bio initiated with an Outperform at Scotiabank
5M ago
INMB
INmune Bio reports Q2 EPS (50c), consensus (63c)
Premium
The Fly
INmune Bio reports Q2 EPS (50c), consensus (63c)
6M ago
INMB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >